List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Brigatinib Tablet Product Introduction
1.2 Market by Type
1.2.1 Global Brigatinib Tablet Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 30mg
1.2.3 50mg
1.2.4 180mg
1.3 Market by Application
1.3.1 Global Brigatinib Tablet Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Brigatinib Tablet Sales Estimates and Forecasts 2017-2028
2.2 Global Brigatinib Tablet Revenue Estimates and Forecasts 2017-2028
2.3 Global Brigatinib Tablet Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Brigatinib Tablet Sales by Region
2.4.1 Global Brigatinib Tablet Sales by Region (2017-2022)
2.4.2 Global Sales Brigatinib Tablet by Region (2023-2028)
2.5 Global Brigatinib Tablet Revenue by Region
2.5.1 Global Brigatinib Tablet Revenue by Region (2017-2022)
2.5.2 Global Brigatinib Tablet Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Brigatinib Tablet Sales by Manufacturers
3.1.1 Global Top Brigatinib Tablet Manufacturers by Sales (2017-2022)
3.1.2 Global Brigatinib Tablet Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Brigatinib Tablet in 2021
3.2 Global Brigatinib Tablet Revenue by Manufacturers
3.2.1 Global Brigatinib Tablet Revenue by Manufacturers (2017-2022)
3.2.2 Global Brigatinib Tablet Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Brigatinib Tablet Revenue in 2021
3.3 Global Brigatinib Tablet Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Brigatinib Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Brigatinib Tablet Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Brigatinib Tablet Sales by Type
4.1.1 Global Brigatinib Tablet Historical Sales by Type (2017-2022)
4.1.2 Global Brigatinib Tablet Forecasted Sales by Type (2023-2028)
4.1.3 Global Brigatinib Tablet Sales Market Share by Type (2017-2028)
4.2 Global Brigatinib Tablet Revenue by Type
4.2.1 Global Brigatinib Tablet Historical Revenue by Type (2017-2022)
4.2.2 Global Brigatinib Tablet Forecasted Revenue by Type (2023-2028)
4.2.3 Global Brigatinib Tablet Revenue Market Share by Type (2017-2028)
4.3 Global Brigatinib Tablet Price by Type
4.3.1 Global Brigatinib Tablet Price by Type (2017-2022)
4.3.2 Global Brigatinib Tablet Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Brigatinib Tablet Sales by Application
5.1.1 Global Brigatinib Tablet Historical Sales by Application (2017-2022)
5.1.2 Global Brigatinib Tablet Forecasted Sales by Application (2023-2028)
5.1.3 Global Brigatinib Tablet Sales Market Share by Application (2017-2028)
5.2 Global Brigatinib Tablet Revenue by Application
5.2.1 Global Brigatinib Tablet Historical Revenue by Application (2017-2022)
5.2.2 Global Brigatinib Tablet Forecasted Revenue by Application (2023-2028)
5.2.3 Global Brigatinib Tablet Revenue Market Share by Application (2017-2028)
5.3 Global Brigatinib Tablet Price by Application
5.3.1 Global Brigatinib Tablet Price by Application (2017-2022)
5.3.2 Global Brigatinib Tablet Price Forecast by Application (2023-2028)
6 North America
6.1 North America Brigatinib Tablet Market Size by Type
6.1.1 North America Brigatinib Tablet Sales by Type (2017-2028)
6.1.2 North America Brigatinib Tablet Revenue by Type (2017-2028)
6.2 North America Brigatinib Tablet Market Size by Application
6.2.1 North America Brigatinib Tablet Sales by Application (2017-2028)
6.2.2 North America Brigatinib Tablet Revenue by Application (2017-2028)
6.3 North America Brigatinib Tablet Market Size by Country
6.3.1 North America Brigatinib Tablet Sales by Country (2017-2028)
6.3.2 North America Brigatinib Tablet Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Brigatinib Tablet Market Size by Type
7.1.1 Europe Brigatinib Tablet Sales by Type (2017-2028)
7.1.2 Europe Brigatinib Tablet Revenue by Type (2017-2028)
7.2 Europe Brigatinib Tablet Market Size by Application
7.2.1 Europe Brigatinib Tablet Sales by Application (2017-2028)
7.2.2 Europe Brigatinib Tablet Revenue by Application (2017-2028)
7.3 Europe Brigatinib Tablet Market Size by Country
7.3.1 Europe Brigatinib Tablet Sales by Country (2017-2028)
7.3.2 Europe Brigatinib Tablet Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Brigatinib Tablet Market Size by Type
8.1.1 Asia Pacific Brigatinib Tablet Sales by Type (2017-2028)
8.1.2 Asia Pacific Brigatinib Tablet Revenue by Type (2017-2028)
8.2 Asia Pacific Brigatinib Tablet Market Size by Application
8.2.1 Asia Pacific Brigatinib Tablet Sales by Application (2017-2028)
8.2.2 Asia Pacific Brigatinib Tablet Revenue by Application (2017-2028)
8.3 Asia Pacific Brigatinib Tablet Market Size by Region
8.3.1 Asia Pacific Brigatinib Tablet Sales by Region (2017-2028)
8.3.2 Asia Pacific Brigatinib Tablet Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Brigatinib Tablet Market Size by Type
9.1.1 Latin America Brigatinib Tablet Sales by Type (2017-2028)
9.1.2 Latin America Brigatinib Tablet Revenue by Type (2017-2028)
9.2 Latin America Brigatinib Tablet Market Size by Application
9.2.1 Latin America Brigatinib Tablet Sales by Application (2017-2028)
9.2.2 Latin America Brigatinib Tablet Revenue by Application (2017-2028)
9.3 Latin America Brigatinib Tablet Market Size by Country
9.3.1 Latin America Brigatinib Tablet Sales by Country (2017-2028)
9.3.2 Latin America Brigatinib Tablet Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Brigatinib Tablet Market Size by Type
10.1.1 Middle East and Africa Brigatinib Tablet Sales by Type (2017-2028)
10.1.2 Middle East and Africa Brigatinib Tablet Revenue by Type (2017-2028)
10.2 Middle East and Africa Brigatinib Tablet Market Size by Application
10.2.1 Middle East and Africa Brigatinib Tablet Sales by Application (2017-2028)
10.2.2 Middle East and Africa Brigatinib Tablet Revenue by Application (2017-2028)
10.3 Middle East and Africa Brigatinib Tablet Market Size by Country
10.3.1 Middle East and Africa Brigatinib Tablet Sales by Country (2017-2028)
10.3.2 Middle East and Africa Brigatinib Tablet Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 ARIAD Pharmaceuticals
11.1.1 ARIAD Pharmaceuticals Corporation Information
11.1.2 ARIAD Pharmaceuticals Overview
11.1.3 ARIAD Pharmaceuticals Brigatinib Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 ARIAD Pharmaceuticals Brigatinib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ARIAD Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Brigatinib Tablet Industry Chain Analysis
12.2 Brigatinib Tablet Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Brigatinib Tablet Production Mode & Process
12.4 Brigatinib Tablet Sales and Marketing
12.4.1 Brigatinib Tablet Sales Channels
12.4.2 Brigatinib Tablet Distributors
12.5 Brigatinib Tablet Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Brigatinib Tablet Industry Trends
13.2 Brigatinib Tablet Market Drivers
13.3 Brigatinib Tablet Market Challenges
13.4 Brigatinib Tablet Market Restraints
14 Key Findings in The Global Brigatinib Tablet Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
